{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:16:43Z","timestamp":1768868203767,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Arch Occup Environ Health"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The handling of antineoplastic drugs represents an occupational health risk for employees in pharmacies. To minimize exposure and to evaluate cleaning efficacy, wipe sampling was used to analyze antineoplastic drugs on surfaces. In 2009, guidance values were suggested to facilitate the interpretation of results, leading to a decrease in surface contamination. The goal of this follow-up was to evaluate the time trend of surface contamination, to identify critical antineoplastic drugs and sampling locations and to reassess guidance values.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Platinum, 5-fluorouracil, cyclophosphamide, ifosfamide, gemcitabine, methotrexate, docetaxel and paclitaxel were analyzed in more than 17,000 wipe samples from 2000 to 2021. Statistical analysis was performed to describe and interpret the data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Surface contaminations were generally relatively low. The median concentration for most antineoplastic drugs was below the limit of detection except for platinum (0.3\u00a0pg\/cm<jats:sup>2<\/jats:sup>). Only platinum and 5-fluorouracil showed decreasing levels over time. Most exceedances of guidance values were observed for platinum (26.9%), cyclophosphamide (18.5%) and gemcitabine (16.6%). The most affected wipe sampling locations were isolators (24.4%), storage areas (17.6%) and laminar flow hoods (16.6%). However, areas with no direct contact to antineoplastic drugs were also frequently contaminated (8.9%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Overall, the surface contaminations with antineoplastic drugs continue to decrease or were generally at a low level. Therefore, we adjusted guidance values according to the available data. The identification of critical sampling locations may help pharmacies to further improve cleaning procedure and reduce the risk of occupational exposure to antineoplastic drugs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00420-023-01963-y","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T11:30:32Z","timestamp":1678102232000},"page":"675-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of long-term data on surface contamination by antineoplastic drugs in pharmacies"],"prefix":"10.1007","volume":"96","author":[{"given":"Caroline","family":"Quartucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P. K.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4851-513X","authenticated-orcid":false,"given":"Stefan","family":"Rakete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"issue":"7","key":"1963_CR1","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00420-021-01671-5","volume":"94","author":"L Bl\u00e1hov\u00e1","year":"2021","unstructured":"Bl\u00e1hov\u00e1 L, Kuta J, Dole\u017ealov\u00e1 L, Koz\u00e1kov\u00e1 \u0160, Krovov\u00e1 T, Bl\u00e1ha L (2021) The efficiency of antineoplastic drug contamination removal by widely used disinfectants-laboratory and hospital studies. Int Arch Occup Environ Health 94(7):1687\u20131702. https:\/\/doi.org\/10.1007\/s00420-021-01671-5","journal-title":"Int Arch Occup Environ Health"},{"issue":"3","key":"1963_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1515\/pthp-2016-0010","volume":"1","author":"A B\u00f6hlandt","year":"2016","unstructured":"B\u00f6hlandt A, Schierl R (2016) Benefits of Wipe Sampling: Evaluation of Long-Term 5-Fluorouracil and Platinum Monitoring Data. Pharm Technol Hops Pharm 1(3):139\u2013150. https:\/\/doi.org\/10.1515\/pthp-2016-0010","journal-title":"Pharm Technol Hops Pharm"},{"issue":"8","key":"1963_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/2Fs00420-007-0181-4","volume":"80","author":"EEM Brouwers","year":"2007","unstructured":"Brouwers EEM, Huiteme ADR, Bakker EN, Douma JW, Schimmel KJM, van Weringh G, de Wolf PJ, Schellens JHM, Beijnen JH (2007) Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry. Int Arch Occup Environ Health 80(8):689\u201399. https:\/\/doi.org\/10.1007\/2Fs00420-007-0181-4","journal-title":"Int Arch Occup Environ Health"},{"issue":"2","key":"1963_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/1078155221992103","volume":"28","author":"C Chabut","year":"2021","unstructured":"Chabut C, Tanguay C, Gagne S, Caron N, Bussieres JF (2021) Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program. J Oncol Pharm Pract 28(2):343\u2013352. https:\/\/doi.org\/10.1177\/1078155221992103","journal-title":"J Oncol Pharm Pract"},{"key":"1963_CR5","doi-asserted-by":"publisher","unstructured":"Colombo M, Jeronimo M, Astrakianakis G, Apte C, Hon CY (2017) Wipe sampling method and evaluation of environmental variables for assessing surface contamination of 10 antineoplastic drugs by liquid chromatography\/tandem mass spectrometry. Ann Work Expo Health 61(8):1003\u20131014. https:\/\/doi.org\/10.1093\/annweh\/wxx070","DOI":"10.1093\/annweh\/wxx070"},{"issue":"9","key":"1963_CR6","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/JOM.0000000000000249","volume":"56","author":"TH Connor","year":"2014","unstructured":"Connor TH, Lawson CC, Polovich M, McDiarmid MA (2014) Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence. J Occup Environ Med 56(9):901\u2013910. https:\/\/doi.org\/10.1097\/JOM.0000000000000249","journal-title":"J Occup Environ Med"},{"issue":"7\u20138","key":"1963_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/15459624.2020.1776299","volume":"17","author":"M Crul","year":"2020","unstructured":"Crul M, Hilhorst S, Breukels O, Bouman-d\u2019Onofrio JRC, Stubbs P, van Rooij JG (2020) Occupational exposure of pharmacy technicians and cleaning staff to cytotoxic drugs in Dutch hospitals. J Occup Environ Hyg 17(7\u20138):343\u2013352. https:\/\/doi.org\/10.1080\/15459624.2020.1776299","journal-title":"J Occup Environ Hyg"},{"issue":"2","key":"1963_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/10781552211072877","volume":"29","author":"C Delafoy","year":"2023","unstructured":"Delafoy C, Roussy C, Hudon A, Cirtiu CM, Caron N, Bussi\u00e8res J, Tanguay C (2023) Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 122 centers. J Oncol Pharm Pract 29(2):338\u2013347. https:\/\/doi.org\/10.1177\/10781552211072877","journal-title":"J Oncol Pharm Pract"},{"key":"1963_CR9","doi-asserted-by":"publisher","unstructured":"Dugheri S, Bonari A, Pompilio I, Boccalon P, Tognoni D, Cecchi M, Ughi M, Mucci N, Arcangeli G (2018) Analytical strategies for assessing occupational exposure to antineoplastic drugs in healthcare workplaces. Med Pr 69(6):589\u2013604. https:\/\/doi.org\/10.13075\/mp.5893.00724","DOI":"10.13075\/mp.5893.00724"},{"issue":"1","key":"1963_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/15459624.2018.1526384","volume":"16","author":"M Federici","year":"2019","unstructured":"Federici M, Raffaelli J, Paolucci D, Schierl R, Kr\u00e4mer I (2019) Efficacy of four cleaning solutions for the decontamination of selected cytotoxic drugs on the different surfaces of an automated compounding system. J Occup Environ Hyg 16(1):6\u201315. https:\/\/doi.org\/10.1080\/15459624.2018.1526384","journal-title":"J Occup Environ Hyg"},{"issue":"5","key":"1963_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00420-004-0595-1","volume":"78","author":"W Fransman","year":"2005","unstructured":"Fransman W, Vermeulen R, Kromhout H (2005) Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health 78(5):403\u2013412. https:\/\/doi.org\/10.1007\/s00420-004-0595-1","journal-title":"Int Arch Occup Environ Health"},{"key":"1963_CR12","doi-asserted-by":"publisher","unstructured":"Gerding J EU (2018) Gef\u00e4hrdungsbeurteilung f\u00fcr T\u00e4tigkeiten mit monoklonalen Antik\u00f6rpern im Gesundheitsdienst. ASU Arbeitsmed Sozialmed Umweltmed 53:242\u2013247. https:\/\/doi.org\/10.17147\/ASU.2018-04-05-02","DOI":"10.17147\/ASU.2018-04-05-02"},{"issue":"18","key":"1963_CR13","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.2146\/ajhp050258","volume":"63","author":"BR Harrison","year":"2006","unstructured":"Harrison BR, Peters BG, Bing MR (2006) Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. Am J Health-Syst Pharm 63(18):1736\u20131744. https:\/\/doi.org\/10.2146\/ajhp050258","journal-title":"Am J Health-Syst Pharm"},{"issue":"2","key":"1963_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/1078155219868525","volume":"26","author":"D Hilliquin","year":"2020","unstructured":"Hilliquin D, Bussi\u00e8res J (2020) External contamination of antineoplastic drug containers from a Canadian wholesaler. J Oncol Pharm Pract 26(2):423\u2013427. https:\/\/doi.org\/10.1177\/1078155219868525","journal-title":"J Oncol Pharm Pract"},{"issue":"7","key":"1963_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1080\/15459624.2013.789743","volume":"10","author":"CY Hon","year":"2013","unstructured":"Hon CY, Teschke K, Chu W, Demers P, Venners S (2013) Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. J Occup Environ Hyg 10(7):374\u2013383. https:\/\/doi.org\/10.1080\/15459624.2013.789743","journal-title":"J Occup Environ Hyg"},{"key":"1963_CR16","unstructured":"International Agency for Research on Cancer (IARC, 2000) Monographs on the evaluation of carcinogenic risks to humans. Some antiviral and antineoplastic drugs, and other pharmaceutical agents. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 76."},{"issue":"23","key":"1963_CR17","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1007\/s00216-015-8868-y","volume":"407","author":"M Jeronimo","year":"2015","unstructured":"Jeronimo M, Colombo M, Astrakianakis G, Hon CY (2015) A surface wipe sampling and LC-MS\/MS method for the simultaneous detection of six antineoplastic drugs commonly handled by healthcare workers. Anal Bioanal Chem 407(23):7083\u20137092. https:\/\/doi.org\/10.1007\/s00216-015-8868-y","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"1963_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/annhyg\/mes081","volume":"57","author":"TK Kiffmeyer","year":"2013","unstructured":"Kiffmeyer TK, Tuerk J, Hahn M, Stuetzer H, Hadtstein C, Heinemann A, Eickmann U (2013) Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project. Ann Occup Hyg 57(4):444\u2013455. https:\/\/doi.org\/10.1093\/annhyg\/mes081","journal-title":"Ann Occup Hyg"},{"issue":"2","key":"1963_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/op9.0000000000000024","volume":"3","author":"E Korczowska","year":"2020","unstructured":"Korczowska E, Crul M, Tuerk J, Meier K (2020) Environmental contamination with cytotoxic drugs in 15 hospitals from 11 European countries\u2014results of the MASHA project. Eur J Oncol Pharm 3(2):e24. https:\/\/doi.org\/10.1097\/op9.0000000000000024","journal-title":"Eur J Oncol Pharm"},{"issue":"7","key":"1963_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/s0003-4878(00)00050-8","volume":"44","author":"H Kromhout","year":"2000","unstructured":"Kromhout H, Hoek F, Uitterhoeve R, Huijbers R, Ottermars RF, Anzion R, Vermeulen R (2000) Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg 44(7):551\u2013560. https:\/\/doi.org\/10.1016\/s0003-4878(00)00050-8","journal-title":"Ann Occup Hyg"},{"issue":"1","key":"1963_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/01.NAJ.0000552583.69729.51","volume":"119","author":"CC Lawson","year":"2019","unstructured":"Lawson CC, Johnson CY, Nassan FL, Connor TH, Boiano JM, Rocheleau CM, Chavarro JE, Rich-Edwards JW (2019) CE: Original Research: Antineoplastic Drug Administration by Pregnant and Nonpregnant Nurses: An Exploration of the Use of Protective Gloves and Gowns. Am J Nurs 119(1):28\u201335. https:\/\/doi.org\/10.1097\/01.NAJ.0000552583.69729.51","journal-title":"Am J Nurs"},{"issue":"2","key":"1963_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10661-016-5762-9","volume":"189","author":"P Marie","year":"2017","unstructured":"Marie P, Christophe C, Manon R, Marc M, Charleric B, Patrice V (2017) Environmental monitoring by surface sampling for cytotoxics: a review. Environ Monit Assess 189(2):52. https:\/\/doi.org\/10.1007\/s10661-016-5762-9","journal-title":"Environ Monit Assess"},{"issue":"1","key":"1963_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/1078155217726160","volume":"25","author":"PI Mathias","year":"2019","unstructured":"Mathias PI, MacKenzie BA, Toennis CA, Connor TH (2019) Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries. J Oncol Pharm Pract 25(1):148\u2013162. https:\/\/doi.org\/10.1177\/1078155217726160","journal-title":"J Oncol Pharm Pract"},{"issue":"3","key":"1963_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/19338244.2013.763757","volume":"69","author":"P Odraska","year":"2014","unstructured":"Odraska P, Dolezalova L, Kuta J, Oravec M, Piler P, Synek S, Blaha L (2014) Association of surface contamination by antineoplastic drugs with different working conditions in hospital pharmacies. Arch Environ Occup Health 69(3):148\u2013158. https:\/\/doi.org\/10.1080\/19338244.2013.763757","journal-title":"Arch Environ Occup Health"},{"issue":"8","key":"1963_CR25","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1177\/1078155220907125","volume":"26","author":"M Palamini","year":"2020","unstructured":"Palamini M, Gagne S, Caron N, Bussieres JF (2020) Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results. J Oncol Pharm Pract 26(8):1921\u20131930. https:\/\/doi.org\/10.1177\/1078155220907125","journal-title":"J Oncol Pharm Pract"},{"key":"1963_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2022-108623","author":"G Saint-Lorant","year":"2023","unstructured":"Saint-Lorant G, Vasseur M, Allorge D, Beauval N, Simon N, Odou P (2023) Four-year follow-up of surface contamination by antineoplastic drugs in a compounding unit. Occup Environ Med. https:\/\/doi.org\/10.1136\/oemed-2022-108623","journal-title":"Occup Environ Med"},{"issue":"7","key":"1963_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/annhyg\/mep050","volume":"53","author":"R Schierl","year":"2009","unstructured":"Schierl R, Bohlandt A, Nowak D (2009) Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Ann Occup Hyg 53(7):703\u2013711. https:\/\/doi.org\/10.1093\/annhyg\/mep050","journal-title":"Ann Occup Hyg"},{"issue":"1","key":"1963_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/1078155214551316","volume":"22","author":"R Schierl","year":"2016","unstructured":"Schierl R, Masini C, Groeneveld S, Fischer E, B\u00f6hlandt A, Rosini V, Paolucci D (2016) Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo. J Oncol Pharm Pract 22(1):37\u201345. https:\/\/doi.org\/10.1177\/1078155214551316","journal-title":"J Oncol Pharm Pract"},{"issue":"10","key":"1963_CR29","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/ajhp\/59.10.956","volume":"59","author":"G Schmaus","year":"2002","unstructured":"Schmaus G, Schierl R, Funck S (2002) Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am J Health Syst Pharm 59(10):956\u2013961. https:\/\/doi.org\/10.1093\/ajhp\/59.10.956","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"1963_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00420-017-1196-0","volume":"90","author":"V Segner","year":"2017","unstructured":"Segner V, Kimbel R, Jochems P, Heinemann A, Letzel S, Wollschl\u00e4ger D, Rossbach B (2017) Liquid release as a source of potential drug exposure during the handling of intravenous infusions in nursing. Int Arch Occup Environ Health 90(3):275\u2013284. https:\/\/doi.org\/10.1007\/s00420-017-1196-0","journal-title":"Int Arch Occup Environ Health"},{"issue":"3","key":"1963_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/00039896.1994.9940377","volume":"49","author":"PJ Sessink","year":"1994","unstructured":"Sessink PJ, Van de Kerkhof MC, Anzion RB, Noordhoek J, Bos RP (1994) Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch Environ Health 49(3):165\u2013169. https:\/\/doi.org\/10.1080\/00039896.1994.9940377","journal-title":"Arch Environ Health"},{"issue":"1","key":"1963_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1078155210361431","volume":"17","author":"PJ Sessink","year":"2011","unstructured":"Sessink PJ, Connor TH, Jorgenson JA, Tyler TG (2011) Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device. J Oncol Pharm Pract 17(1):39\u201348. https:\/\/doi.org\/10.1177\/1078155210361431","journal-title":"J Oncol Pharm Pract"},{"key":"1963_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/10781552231151693","author":"LS Silva","year":"2003","unstructured":"Silva LS, da Silva Barbosa Mchado C, Linden R, Venzon Antunes M, da Silva LC, Yasin Wayhs CA, Capp E, Ribeiro Ness SL (2003) Residual contamination in antineoplastic drug packaging. J Oncol Pharm Pract. https:\/\/doi.org\/10.1177\/10781552231151693","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"1963_CR34","first-page":"72","volume":"26","author":"S Soefje","year":"2022","unstructured":"Soefje S, Rickabaugh K, Rajkumar R, Wall KP (2022) Evaluation of closed-system transfer devices in reducing potential risk for surface contamination following simulated hazardous-drug preparation and compounding. Int J Pharm Compd 26(1):72\u201379","journal-title":"Int J Pharm Compd"},{"issue":"27","key":"1963_CR35","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1016\/j.jchromb.2010.04.030","volume":"878","author":"C Sottani","year":"2010","unstructured":"Sottani C, Porro B, Comelli M, Imbriani M, Minoia C (2010) An analysis to study trends in occupational exposure to antineoplastic drugs among health care workers. J Chromatogr B Analyt Technol Biomed Life Sci 878(27):2593\u2013605. https:\/\/doi.org\/10.1016\/j.jchromb.2010.04.030","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"8","key":"1963_CR36","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/annweh\/wxx065","volume":"61","author":"C Sottani","year":"2017","unstructured":"Sottani C, Grignani E, Oddone E, Dezza B, Negri S, Villani S, Cottica D (2017) Monitoring surface contamination by antineoplastic drugs in Italian hospitals: performance-based hygienic guidance values (HGVs) Project. Ann Work Expo Health 61(8):994\u20131002. https:\/\/doi.org\/10.1093\/annweh\/wxx065","journal-title":"Ann Work Expo Health"},{"key":"1963_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19148601","author":"C Sottani","year":"2022","unstructured":"Sottani C, Grignani E, Cornacchia M, Negri S, Saverio Robustelli Della Cuna F, Cottica D, Bruzzese D, Severi P, Strocci D, Verna G, Leso V, Iavicoli I (2022) Occupational exposure assessment to antineoplastic drugs in nine Italian hospital centers over a 5-year survey program. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph19148601","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1963_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.toxlet.2011.08.022","volume":"207","author":"A Suspiro","year":"2011","unstructured":"Suspiro A, Prista J (2011) Biomarkers of occupational exposure do anticancer agents: a minireview. Toxicol Lett 207(1):42\u201352. https:\/\/doi.org\/10.1016\/j.toxlet.2011.08.022","journal-title":"Toxicol Lett"}],"container-title":["International Archives of Occupational and Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00420-023-01963-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00420-023-01963-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00420-023-01963-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T09:11:10Z","timestamp":1685092270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00420-023-01963-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1963"],"URL":"https:\/\/doi.org\/10.1007\/s00420-023-01963-y","relation":{},"ISSN":["0340-0131","1432-1246"],"issn-type":[{"value":"0340-0131","type":"print"},{"value":"1432-1246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"assertion":[{"value":"18 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institute and Clinic for Occupational, Social and Environmental Medicine at the University Hospital of the LMU Munich offers non-commercial analysis of antineoplastic drugs in wipe samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable. This study does not involve human participants, their data or biological material.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable. This study does not involve human participants, their data or biological material.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. This study does not involve human participants, their data or biological material.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}